IN8bio Inc (NASDAQ:INAB) shares, rose in value on Friday, March 28, with the stock price down by -5.77% to the previous day’s close as strong demand from buyers drove the stock to $0.20.
Actively observing the price movement in the last trading, the stock closed the session at $0.21, falling within a range of $0.1912 and $0.21. The value of beta (5-year monthly) was 0.025. Referring to stock’s 52-week performance, its high was $1.74, and the low was $0.19. On the whole, INAB has fluctuated by -22.61% over the past month.
With the market capitalization of IN8bio Inc currently standing at about $15.93 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that INAB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of INAB currently trading nearly -16.50% and -24.30% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 30.32, while the 7-day volatility ratio is showing 9.65% which for the 30-day chart, stands at 9.73%. Furthermore, IN8bio Inc (INAB)’s beta value is 0.12, and its average true range (ATR) is 0.02.
A comparison of IN8bio Inc (INAB) with its peers suggests the former has fared considerably weaker in the market. INAB showed an intraday change of -5.77% in last session, and over the past year, it shrunk by -84.31%%.
Data on historical trading for IN8bio Inc (NASDAQ:INAB) indicates that the trading volumes over the past 10 days have averaged 0.84 and over the past 3 months, they’ve averaged 5.51 million. According to company’s latest data on outstanding shares, there are 72.48 million shares outstanding.
Nearly 20.35% of IN8bio Inc’s shares belong to company insiders and institutional investors own 30.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.67 million shares as on 2025-03-14, resulting in a short ratio of 0.67. According to the data, the short interest in IN8bio Inc (INAB) stood at 246.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.76 million. The stock has fallen by -23.76% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the INAB stock heading into the next quarter.
